Skip to main content Accessibility help
×
Home
  • Print publication year: 2012
  • Online publication date: August 2012

3 - Pathophysiology of the androgen receptor

3.8 References

AbdullahA, TrifiroMA, Panet-RaymondV, AlvaradoC, de TourreilS, FrankelD, SchipperHM, PinskyL (1998) Spinobulbar muscular atrophy: polyglutamine-expanded androgen receptor is proteolytically resistant in vitro and processed abnormally in transfected cells. Hum Mol Genet 7:379–384
AdachiM, TakayanagiR, TomuraA, ImasakiK, KatoS, GotoK, YanaseT, IkuyamaS, NawataH (2000) Androgen-insensitivity syndrome as a possible coactivator disease. N Engl J Med 343:856–862
AhmedSF, AchermannJC, ArltW, BalenA, ConwayG, EdwardsZ, ElfordS, HughesIA, IzattL, KroneN, MilesH, O'TooleS, PerryL, SandersC, SimmondsM, Michael WallaceA, WattA, WillisD (2011) UK guidance on the initial evaluation of an infant or an adolescent with a suspected disorder of sex development. Clin Endocrinol (Oxf) 75:12–26
AimanJ, GriffinJE, GazakJM, WilsonJD, MacDonaldPC (1979) Androgen insensitivity as a cause of infertility in otherwise normal men. N Engl J Med 300:223–227
AlbertelliMA, SchellerA, BrogleyM, RobinsDM (2006) Replacing the mouse androgen receptor with human alleles demonstrates glutamine tract length-dependent effects on physiology and tumorigenesis in mice. Mol Endocrinol 20:1248–1260
AnderssonS, BermanDM, JenkinsEP, RussellDW (1991) Deletion of steroid 5 alpha-reductase 2 gene in male pseudohermaphroditism. Nature 354:159–161
AppariM, WernerR, WunschL, CarioG, DemeterJ, HiortO, RiepeFJ, HolterhusPM (2009) Apolipoprotein D (APOD) is a putative biomarker of androgen receptor function in androgen insensitivity syndrome. J Mol Med 87:623–632
ArbizuT, SantamariaJ, GomezJM, QuilezA, SerraJP (1983) A family with adult onset spinal and bulbar muscular atrophy X-linked inheritance and associated testicular failure. J Neurol Sci 59:371–382
BalicI, GrahamST, TroyerDA, HigginsBA, PollockBH, Johnson-PaisTL, ThompsonIM, LeachRJ (2002) Androgen receptor length polymorphism associated with prostate cancer risk in Hispanic men. J Urol 168:2245–2248
Barrett-ConnorE, von MühlenDG, Kritz-SilversteinD (1999) Bioavailable testosterone and depressed mood in older men: the Rancho Bernardo Study. J Clin Endocr Metab 84:573–577
BarsoumIB, YaoHH (2010) Fetal Leydig cells: progenitor cell maintenance and differentiation. J Androl 31:11–15
BarsoumIB, BinghamNC, ParkerKL, JorgensenJS, YaoHH (2009) Activation of the Hedgehog pathway in the mouse fetal ovary leads to ectopic appearance of fetal Leydig cells and female pseudohermaphroditism. Dev Biol 329:96–103
BebermeierJH, BrooksJD, DeprimoSE, WernerR, DeppeU, DemeterJ, HiortO, HolterhusPM (2006) Cell-line and tissue-specific signatures of androgen receptor-coregulator transcription. J Mol Med 84:919–931
BeilinJ, HarewoodL, FrydenbergM, MameghanH, MartyresRF, FarishSJ, YueC, DeamDR, ByronKA, ZajacJD (2001) A case-control study of the androgen receptor gene CAG repeat polymorphism in Australian prostate carcinoma subjects. Cancer 92:941–949
BhasinS, WoodhouseL, CasaburiR, SinghAB, BhasinD, BermanN, ChenX, YarasheskiKE, MaglianoL, DzekovC, DzekovJ, BrossR, PhillipsJ, Sinha-HikimI, ShenR, StorerTW (2001) Testosterone dose-response relationships in healthy young men. Am J Physiol Endocrinol Metab 281:1172–1181
Bhatia-GaurR, DonjacourAA, SciavolinoPJ, KimM, DesaiN, YoungP, NortonCR, GridleyT, CardiffRD, CunhaGR, Abate-ShenC, ShenMM (1999) Roles for Nkx3.1 in prostate development and cancer. Genes Dev 13:966–977
BieberichCJ, FujitaK, HeWW, JayG (1996) Prostate-specific and androgen-dependent expression of a novel homeobox gene. J Biol Chem 271:31779–31782
BoehmerAL, BrinkmannO, BruggenwirthH, van AssendelftC, OttenBJ, Verleun-MooijmanMC, NiermeijerMF, BrunnerHG, RouweCW, WaelkensJJ, OostdijkW, KleijerWJ, van der KwastTH, de VroedeMA, DropSL (2001) Genotype versus phenotype in families with androgen insensitivity syndrome. J Clin Endocrinol Metab 86:4151–4160
BoukariK, MeduriG, Brailly-TabardS, GuibourdencheJ, CiampiML, MassinN, MartinerieL, PicardJY, ReyR, LombesM, YoungJ (2009) Lack of androgen receptor expression in Sertoli cells accounts for the absence of anti-Mullerian hormone repression during early human testis development. J Clin Endocrinol Metab 94:1818–1825
BouvattierC, CarelJC, LecointreC, DavidA, SultanC, BertrandAM, MorelY, ChaussainJL (2002) Postnatal changes of T, LH, and FSH in 46,XY infants with mutations in the AR gene. J Clin Endocrinol Metab 87:29–32
BullejosM, KoopmanP (2001) Spatially dynamic expression of Sry in mouse genital ridges. Dev Dyn 221:201–205
BurrisAS, BanksSM, CarterCS, DavidsonJM, SherinsRJ (1992) A long-term prospective study of the physiologic and behavioural effects of hormone replacement in untreated hypogonadal men. J Androl 13:297–304
CanaleD, CaglieresiC, MoschiniC, LiberatiCD, MacchiaE, PincheraA, MartinoE (2005) Androgen receptor polymorphism (CAG repeats) and androgenicity. Clin Endocrinol (Oxf) 63:356–361
ChamberlainNL, DriverED, MiesfeldRL (1994) The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function. Nucleic Acids Res 22:3181–3186
ChamberlainNL, WhitacreDC, MiesfeldRL (1996) Delineation of two distinct type 1 activation functions in the androgen receptor amino-terminal domain. J Biol Chem 271:26772–26778
ChangCS, KokontisJ, LiaoST (1988) Molecular cloning of human and rat complementary DNA encoding androgen receptors. Science 240:324–326
ChenHY, ChenWC, WuMC, TsaiFJ, TsaiCH (2003) Androgen receptor (AR) gene microsatellite polymorphism in postmenopausal women: correlation to bone mineral density and susceptibility to osteoporosis. Eur J Obstet Gynecol Reprod Biol 107:52–56
ChoongCS, WilsonEM (1998) Trinucleotide repeats in the human androgen receptor: a molecular basis for disease. J Mol Endocrinol 21:235–257
ClaessensF, VerrijdtG, SchoenmakersE, HaelensA, PeetersB, VerhoevenG, RombautsW (2001) Selective DNA binding by the androgen receptor as a mechanism for hormone-specific gene regulation. J Steroid Biochem Mol Biol 76:23–30
ClaessensF, DenayerS, Van TilborghN, KerkhofsS, HelsenC, HaelensA (2008) Diverse roles of androgen receptor (AR) domains in AR-mediated signaling. Nucl Recept Signal 6:e008
ComingsDE, ChenC, WuS, MuhlemanD (1999) Association of the androgen receptor gene (AR) with ADHD and conduct disorder. Neuroreport 10:1589–1592
CoolsM, WolffenbuttelKP, DropSL, OosterhuisJW, LooijengaLH (2011) Gonadal development and tumor formation at the crossroads of male and female sex determination. Sex Dev 5:167–180
Correa-CerroL, WohrG, HausslerJ, BerthonP, DrelonE, ManginP, FournierG, CussenotO, KrausP, JustW, PaissT, CantuJM, VogelW (1999) (CAG)nCAA and GGN repeats in the human androgen receptor gene are not associated with prostate cancer in a French-German population. Eur J Hum Gen 7:357–362
Coutinho-CamilloCM, MiraccaEC, dos SantosML, SalaorniS, SarkisAS, NagaiMA (2006) Identification of differentially expressed genes in prostatic epithelium in relation to androgen receptor CAG repeat length. Int J Biol Markers 21:96–105
CutressML, WhitakerHC, MillsIG, StewartM, NealDE (2008) Structural basis for the nuclear import of the human androgen receptor. J Cell Sci 121:957–968
da CostaRose PaulinoM, SteinmetzL, Menezes FilhoHC, KupermanH, Della MannaT, VieiraJG, BlasbalgR, BaroniR, SetianN, DamianiD (2009) Search of prostatic tissue in 46,XX congenital adrenal hyperplasia. Arq Bras Endocrinol Metabol 53:716–720
DadzeS, WielandC, JakubiczkaS, FunkeK, SchröderE, Royer-PokoraB, WillersR, WieackerPF (2000) The size of the CAG repeat in exon 1 of the androgen receptor gene shows no significant relationship to impaired spermatogenesis in an infertile Caucasoid sample of German origin. Mol Hum Reprod 6:207–214
Davis-DaoCA, TuazonED, SokolRZ, CortessisVK (2007) Male infertility and variation in CAG repeat length in the androgen receptor gene: a meta-analysis. J Clin Endocrinol Metab 92:4319–4326
DejagerS, Bry-GauillardH, BruckertE, EymardB, SalachasF, LeGuernE, TardieuS, ChadarevianR, GiralP, TurpinG (2002) A comprehensive endocrine description of Kennedy's disease revealing androgen insensitivity linked to CAG repeat length. J Clin Endocr Metab 87:3893–3901
DeslypereJP, YoungM, WilsonJD, McPhaulMJ (1992) Testosterone and 5 alpha-dihydrotestosterone interact differently with the androgen receptor to enhance transcription of the MMTV-CAT reporter gene. Mol Cell Endocrinol 88:15–22
DoehnertU, BertelloniS, Richter-UnruhA, WernerR, HiortO (2011) Hormone profiles in adolescents and adults with complete androgen insensitivity syndrome. In: HiortO (ed) 3rd International Symposium on Disorders of Sex Development, Lübeck. Book of abstracts, Universität zu Lübeck, Lübeck, Germany, p 57
DowsingAT, YongEL, ClarkM, McLachlanRI, de KretserDM, TrounsonAO (1999) Linkage between male infertility and trinucleotide repeat expansion in the androgen-receptor gene. Lancet 354:640–643
DoyuM, SobueG, MukaiE, KachiT, YasudaT, MitsumaT, TakahashiA (1992) Severity of X-linked recessive bulbospinal neuronopathy correlates with size of the tandem CAG repeat in androgen receptor gene. Annals Neurol 32:707–710
EdwardsA, HammondHA, JinL, CaskeyCT, ChakrabortyR (1992) Genetic variation at five trimeric and tetrameric tandem repeat loci in four human population groups. Genomics 12:241–253
EllisJA, StebbingM, HarrapSB (2001) Polymorphism of the androgen receptor gene is associated with male pattern baldness. J Invest Dermatol 116:452–455
GiovannucciE, StampferMJ, KrithivasK, BrownM, DahlD, BrufskyA, TalcottJ, HennekensCH, KantoffPW (1997) The CAG repeat within the androgen receptor gene and its relationship to prostate cancer. Proc Natl Acad Sci 94:3320–3323
GiovannucciE, StampferMJ, ChanA, KrithivasK, GannPH, HennekensCH, KantoffPW (1999a) CAG repeat within the androgen receptor gene and incidence of surgery for benign prostatic hyperplasia in U.S. physicians. Prostate 39:130–134
GiovannucciE, PlatzEA, StampferMJ, ChanA, KrithivasK, KawachiI, WillettWC, KantoffPW (1999b) The CAG repeat within the androgen receptor gene and benign prostatic hyperplasia. Urology 53:121–125
HabertR, LejeuneH, SaezJM (2001) Origin, differentiation and regulation of fetal and adult Leydig cells. Mol Cell Endocrinol 179:47–74
HackerA, CapelB, GoodfellowP, Lovell-BadgeR (1995) Expression of Sry, the mouse sex determining gene. Development 121:1603–1614
HaelensA, VerrijdtG, CallewaertL, ChristiaensV, SchauwaersK, PeetersB, RombautsW, ClaessensF (2003) DNA recognition by the androgen receptor: evidence for an alternative DNA-dependent dimerization, and an active role of sequences flanking the response element on transactivation. Biochem J 369:141–151
HannemaSE, HughesIA (2007) Regulation of Wolffian duct development. Horm Res 67:142–151
HannemaSE, ScottIS, Rajpert-De MeytsE, SkakkebaekNE, ColemanN, HughesIA (2006) Testicular development in the complete androgen insensitivity syndrome. J Pathol 208:518–527
HaraguchiR, MoR, HuiC, MotoyamaJ, MakinoS, ShiroishiT, GaffieldW, YamadaG (2001) Unique functions of Sonic hedgehog signaling during external genitalia development. Development 128:4241–4250
HarkonenK, HuhtaniemiI, MakinenJ, HüblerD, IrjalaK, KoskenvuoM, OettelM, RaitakariO, SaadF, PollanenP (2003) The polymorphic androgen receptor gene CAG repeat pituitary-testicular function and andropausal symptoms in ageing men. Int J Androl 26:187–194
HeB, GampeRT Jr, KoleAJ, HnatAT, StanleyTB, AnG, StewartEL, KalmanRI, MingesJT, WilsonEM (2004) Structural basis for androgen receptor interdomain and coactivator interactions suggests a transition in nuclear receptor activation function dominance. Mol Cell 16:425–438
HellwinkelOJ, BullK, HolterhusPM, HomburgN, StruveD, HiortO (1999) Complete androgen insensitivity caused by a splice donor site mutation in intron 2 of the human androgen receptor gene resulting in an exon 2-lacking transcript with premature stop-codon and reduced expression. J Steroid Biochem Mol Biol 68:1–9
HellwinkelOJ, HolterhusPM, StruveD, MarschkeC, HomburgN, HiortO (2001) A unique exonic splicing mutation in the human androgen receptor gene indicates a physiologic relevance of regular androgen receptor transcript variants. J Clin Endocrinol Metab 86:2569–2575
HiortO, SinneckerGH, HolterhusPM, NitscheEM, KruseK (1996) The clinical and molecular spectrum of androgen insensitivity syndromes. Am J Med Genet 63:218–222
HiortO, SinneckerGH, HolterhusPM, NitscheEM, KruseK (1998) Inherited and de novo androgen receptor gene mutations: investigation of single-case families. J Pediatr 132:939–943
HiortO, HolterhusPM, HorterT, SchulzeW, KremkeB, Bals-PratschM, SinneckerGH, KruseK (2000) Significance of mutations in the androgen receptor gene in males with idiopathic infertility. J Clin Endocrinol Metab 85:2810–2815
HiortO, ReineckeS, ThyenU, JurgensenM, HolterhusPM, SchonD, Richter-AppeltH (2003) Puberty in disorders of somatosexual differentiation. J Pediatr Endocrinol Metab 16 (Suppl 2):297–306
HolterhusPM, WiebelJ, SinneckerGH, BruggenwirthHT, SippellWG, BrinkmannAO, KruseK, HiortO (1999) Clinical and molecular spectrum of somatic mosaicism in androgen insensitivity syndrome. Pediatr Res 46:684–690
HolterhusPM, SinneckerGH, HiortO (2000) Phenotypic diversity and testosterone-induced normalization of mutant L712F androgen receptor function in a kindred with androgen insensitivity. J Clin Endocrinol Metab 85:3245–3250
HolterhusPM, BruggenwirthHT, BrinkmannAO, HiortO (2001) Post-zygotic mutations and somatic mosaicism in androgen insensitivity syndrome. Trends Genet 17:627–628
HolterhusPM, HiortO, DemeterJ, BrownPO, BrooksJD (2003) Differential gene-expression patterns in genital fibroblasts of normal males and 46,XY females with androgen insensitivity syndrome: evidence for early programming involving the androgen receptor. Genome Biol 4:R37
HolterhusPM, DeppeU, WernerR, Richter-UnruhA, BebermeierJH, WunschL, KregeS, SchweikertHU, DemeterJ, RiepeF, HiortO, BrooksJD (2007) Intrinsic androgen-dependent gene expression patterns revealed by comparison of genital fibroblasts from normal males and individuals with complete and partial androgen insensitivity syndrome. BMC Genomics 8:376
HolterhusPM, BebermeierJH, WernerR, DemeterJ, Richter-UnruhA, CarioG, AppariM, SiebertR, RiepeF, BrooksJD, HiortO (2009) Disorders of sex development expose transcriptional autonomy of genetic sex and androgen-programmed hormonal sex in human blood leukocytes. BMC Genomics 10:292
HsiaoPW, LinDL, NakaoR, ChangC (1999) The linkage of Kennedy's neuron disease to ARA24, the first identified androgen receptor polyglutamine region-associated coactivator. J Biol Chem 274:20229–20234
HsingAW, GaoYT, WuG, WangX, DengJ, ChenYL, SesterhennIA, MostofiFK, BenichouJ, ChangC (2000a) Polymorphic CAG and GGN repeat lengths in the androgen receptor gene and prostate cancer risk: a population-based case-control study in China. Cancer Res 60:5111–5116
HsingAW, TsaoL, DevesaSS (2000b) International trends and patterns of prostate cancer incidence and mortality. Int J Cancer 85:60–67
HuangL, PuY, HeppsD, DanielpourD, PrinsGS (2007) Posterior Hox gene expression and differential androgen regulation in the developing and adult rat prostate lobes. Endocrinology 148:1235–1245
HuhtaniemiIT, PyeSR, LimerKL, ThomsonW, O'NeillTW, PlattH, PayneD, JohnSL, JiangM, BoonenS, BorghsH, VanderschuerenD, AdamsJE, WardKA, BartfaiG, CasanuevaF, FinnJD, FortiG, GiwercmanA, HanTS, KulaK, LeanME, PendletonN, PunabM, SilmanAJ, WuFC; European Male Ageing Study Group (2009) Increased estrogen rather than decreased androgen action is associated with longer androgen receptor CAG repeats. J Clin Endocrinol Metab 94:277–284
Imperato-McGinleyJ, SanchezRS, SpencerJR, YeeB, VaughanED (1992) Comparison of the effects of the 5 alpha-reductase inhibitor finasteride and the antiandrogen flutamide on prostate and genital differentiation: dose-response studies. Endocrinology 131:1149–1156
IrvineRA, MaH, YuMC, RossRK, StallcupMR, CoetzeeGA (2000) Inhibition of p160-mediated coactivation with increasing androgen receptor polyglutamine length. Hum Mol Genet 9:267–274
JensterG, van der KorputJA, TrapmanJ, BrinkmannAO (1992) Functional domains of the human androgen receptor. J Steroid Biochem Mol Biol 41:671–675
JensterG, TrapmanJ, BrinkmannAO (1993) Nuclear import of the human androgen receptor. Biochem J 293:761–768
JensterG, van der KorputHA, TrapmanJ, BrinkmannAO (1995) Identification of two transcription activation units in the N-terminal domain of the human androgen receptor. J Biol Chem 270:7341–7346
JönssonEG, von GerttenC, GustavssonJP, YuanQP, Lindblad-TohK, ForslundK, RylanderG, Mattila-EvendenM, AsbergM, SchallingM (2001) Androgen receptor trinucleotide repeat polymorphism and personality traits. Psychiatr Genet 11:19–23
KashimadaK, KoopmanP (2010) Sry: the master switch in mammalian sex determination. Development 137:3921–3930
Kazemi-EsfarjaniP, TrifiroMA, PinskyL (1995) Evidence for a repressive function of the long polyglutamine tract in the human androgen receptor: possible pathogenetic relevance for the (CAG)n-expanded neuronopathies. Hum Mol Genet 4:523–527
KennedyWR, AlterM, SungJH (1968) Progressive proximal spinal and bulbar muscular atrophy of late onset. Neurology 18:671–680
KhoslaS (2002) Oestrogen bones and men: when testosterone just isn't enough. Clin Endocrinol 56:291–293
KimY, KobayashiA, SekidoR, DiNapoliL, BrennanJ, ChaboissierMC, PoulatF, BehringerRR, Lovell-BadgeR, CapelB (2006) Fgf9 and Wnt4 act as antagonistic signals to regulate mammalian sex determination. PLoS Biol 4:e187
KimY, BinghamN, SekidoR, ParkerKL, Lovell-BadgeR, CapelB (2007) Fibroblast growth factor receptor 2 regulates proliferation and Sertoli differentiation during male sex determination. Proc Natl Acad Sci USA 104:16558–16563
KittlesRA, YoungD, WeinrichS, HudsonJ, ArgyropoulosG, UkoliF, Adams-CampbellL, DunstonGM (2001) Extent of linkage disequilibrium between the androgen receptor gene CAG and GGC repeats in human populations: implications for prostate cancer risk. Hum Gen 109:253–261
KlessenC, AsbachP, HeinPA, BeyersdorffD, HammB, TaupitzM (2005) Complex genital malformation in a female with congenital adrenal hyperplasia: evaluation with magnetic resonance imaging. Acta Radiol 46:891–894
KohlerB, LumbrosoS, LegerJ, AudranF, GrauES, KurtzF, PintoG, SalernoM, SemitchevaT, CzernichowP, SultanC (2005) Androgen insensitivity syndrome: somatic mosaicism of the androgen receptor in seven families and consequences for sex assignment and genetic counseling. J Clin Endocrinol Metab 90:106–111
KooyRF, ReyniersE, StormK, VitsL, van VelzenD, de RuiterPE, BrinkmannAO, de PaepeA, WillemsPJ (1999) CAG repeat contraction in the androgen receptor gene in three brothers with mental retardation. Am J Med Gen 85:209–213
KubiniK, ZachmannM, AlbersN, HiortO, BettendorfM, WolfleJ, BidlingmaierF, KlingmullerD (2000) Basal inhibin B and the testosterone response to human chorionic gonadotropin correlate in prepubertal boys. J Clin Endocrinol Metab 85:134–138
KuhlenbäumerG, KressW, RingelsteinEB, StögbauerF (2001) Thirty-seven CAG repeats in the androgen receptor gene in two healthy individuals. J Neurol 248:23–26
KurzrockEA, BaskinLS, LiY, CunhaGR (1999) Epithelial-mesenchymal interactions in development of the mouse fetal genital tubercle. Cells Tissues Organs 164:125–130
LaMarcaHL, RosenJM (2008) Minireview: hormones and mammary cell fate – what will I become when I grow up?Endocrinology 149:4317–4321
LasnitzkiI, MizunoT (1977) Induction of the rat prostate gland by androgens in organ culture. J Endocrinol 74:47–55
LasnitzkiI, MizunoT (1979) Role of the mesenchyme in the induction of the rat prostate gland by androgens in organ culture. J Endocrinol 82:171–178
La SpadaAR, WilsonEM, LubahnDB, HardingAE, FischbeckKH (1991) Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature 352:77–79
LatilAG, AzzouziR, CancelGS, GuillaumeEC, Cochan-PriolletB, BerthonPL, CussenotO (2001) Prostate carcinoma risk and allelic variants of genes involved in androgen biosynthesis and metabolism pathways. Cancer 92:1130–1137
LaveryDN, McEwanIJ (2006) The human androgen receptor AF1 transactivation domain: interactions with transcription factor IIF and molten-globule-like structural characteristics. Biochem Soc Trans 34:1054–1057
LaveryDN, McEwanIJ (2008a) Functional characterization of the native NH2-terminal transactivation domain of the human androgen receptor: binding kinetics for interactions with TFIIF and SRC-1a. Biochemistry 47:3352–3359
LaveryDN, McEwanIJ (2008b) Structural characterization of the native NH2-terminal transactivation domain of the human androgen receptor: a collapsed disordered conformation underlies structural plasticity and protein-induced folding. Biochemistry 47:3360–3369
LegiusE, VanderschuerenD, SpiessensC, D'HoogheT, MatthijsG (1999) Association between CAG repeat number in the androgen receptor and male infertility in a Belgian study. Clin Genet 56:166–167
LimerKL, PyeSR, ThomsonW, BoonenS, BorghsH, VanderschuerenD, HuhtaniemiIT, AdamsJE, WardKA, PlattH, PayneD, JohnSL, BartfaiG, CasanuevaF, FinnJD, FortiG, GiwercmanA, HanTS, KulaK, LeanME, PendletonN, PunabM, SilmanAJ, WuFC, O'NeillTW; EMAS Study Group (2009) Genetic variation in sex hormone genes influences heel ultrasound parameters in middle-aged and elderly men: results from the European Male Aging Study (EMAS). J Bone Miner Res 24:314–323
LubahnDB, JosephDR, SullivanPM, WillardHF, FrenchFS, WilsonEM (1988) Cloning of human androgen receptor complementary DNA and localization to the X chromosome. Science 240:327–330
LubahnDB, BrownTR, SimentalJA, HiggsHN, MigeonCJ, WilsonEM, FrenchFS (1989) Sequence of the intron/exon junctions of the coding region of the human androgen receptor gene and identification of a point mutation in a family with complete androgen insensitivity. Proc Natl Acad Sci USA 86:9534–9538
Lundberg-GiwercmanY, XuC, ArverS, PousetteA, RenelandR (1998) No association between the androgen receptor gene CAG repeat and impaired sperm production in Swedish men. Clin Genet 54:435–436
MahendrooMS, CalaKM, HessDL, RussellDW (2001) Unexpected virilization in male mice lacking steroid 5 alpha-reductase enzymes. Endocrinology 142:4652–4662
MalkiS, NefS, NotarnicolaC, ThevenetL, GascaS, MejeanC, BertaP, PoulatF, Boizet-BonhoureB (2005) Prostaglandin D2 induces nuclear import of the sex-determining factor SOX9 via its cAMP-PKA phosphorylation. EMBO J 24:1798–1809
MangelsdorfDJ, ThummelC, BeatoM, HerrlichP, SchutzG, UmesonoK, BlumbergB, KastnerP, MarkM, ChambonP, EvansRM (1995) The nuclear receptor superfamily: the second decade. Cell 83:835–839
MariottiC, CastellottiB, PareysonD, TestaD, EoliM, AntozziC, SilaniV, MarconiR, TezzonF, SicilianoG, MarchiniC, GelleraC, DonatoSD (2000) Phenotypic manifestations associated with CAG-repeat expansion in the androgen receptor gene in male patients and heterozygous females: a clinical and molecular study of 30 families. Neuromusc Dis 10:391–397
MarkerPC, DonjacourAA, DahiyaR, CunhaGR (2003) Hormonal, cellular, and molecular control of prostatic development. Dev Biol 253:165–174
MarshallGR, WickingsEJ, NieschlagE (1984) Testosterone can initiate spermatogenesis in an immature nonhuman primate, Macaca fascicularis. Endocrinology 114:2228–2233
MatiasPM, DonnerP, CoelhoR, ThomazM, PeixotoC, MacedoS, OttoN, JoschkoS, ScholzP, WeggA, BaslerS, SchaferM, EgnerU, CarrondoMA (2000) Structural evidence for ligand specificity in the binding domain of the human androgen receptor. Implications for pathogenic gene mutations. J Biol Chem 275:26164–26171
MeeksJJ, SchaefferEM (2011) Genetic regulation of prostate development. J Androl 32:210–217
MengualL, OriolaJ, AscasoC, BallescaJL, OlivaR (2003) An increased CAG repeat length in the androgen receptor gene in azoospermic ICSI candidates. J Androl 24:279–284
MifsudA, SimCK, Boettger-TongH, MoreiraS, LambDJ, LipshultzLI, YongEL (2001) Trinucleotide (CAG) repeat polymorphisms in the androgen receptor gene: molecular markers of risk for male infertility. Fertil Steril 75:275–281
MitsumoriK, TeraiA, OkaH, SegawaT, OguraK, YoshidaO, OgawaO (1999) Androgen receptor CAG repeat length polymorphism in benign prostatic hyperplasia (BPH): correlation with adenoma growth. Prostate 41:253–257
MiyagawaS, SatohY, HaraguchiR, SuzukiK, IguchiT, TaketoMM, NakagataN, MatsumotoT, TakeyamaK, KatoS, YamadaG (2009) Genetic interactions of the androgen and Wnt/beta-catenin pathways for the masculinization of external genitalia. Mol Endocrinol 23:871–880
MiyagawaS, MatsumaruD, MurashimaA, OmoriA, SatohY, HaraguchiR, MotoyamaJ, IguchiT, NakagataN, HuiCC, YamadaG (2011) The role of sonic hedgehog-gli2 pathway in the masculinization of external genitalia. Endocrinology 152:2894–2903
MoniotB, DeclosmenilF, BarrionuevoF, SchererG, AritakeK, MalkiS, MarziL, Cohen-SolalA, GeorgI, KlattigJ, EnglertC, KimY, CapelB, EguchiN, UradeY, Boizet-BonhoureB, PoulatF (2009) The PGD2 pathway, independently of FGF9, amplifies SOX9 activity in Sertoli cells during male sexual differentiation. Development 136:1813–1821
MorasD, GronemeyerH (1998) The nuclear receptor ligand-binding domain: structure and function. Curr Opin Cell Biol 10:384–391
MurakamiR, MizunoT (1986) Proximal-distal sequence of development of the skeletal tissues in the penis of rat and the inductive effect of epithelium. J Embryol Exp Morphol 92:133–143
NielsenTL, HagenC, WraaeK, BathumL, LarsenR, BrixenK, AndersenM (2010) The impact of the CAG repeat polymorphism of the androgen receptor gene on muscle and adipose tissues in 20–29-year-old Danish men: Odense Androgen Study. Eur J Endocrinol 162:795–804
NishidaH, MiyagawaS, MatsumaruD, WadaY, SatohY, OginoY, FukudaS, IguchiT, YamadaG (2008) Gene expression analyses on embryonic external genitalia: identification of regulatory genes possibly involved in masculinization processes. Congenit Anom (Kyoto) 48:63–67
O'ShaughnessyPJ, BakerPJ, HeikkilaM, VainioS, McMahonAP (2000) Localization of 17beta-hydroxysteroid dehydrogenase/17-ketosteroid reductase isoform expression in the developing mouse testis – androstenedione is the major androgen secreted by fetal/neonatal Leydig cells. Endocrinology 141:2631–2637
O'ShaughnessyPJ, JohnstonH, WillertonL, BakerPJ (2002) Failure of normal adult Leydig cell development in androgen-receptor-deficient mice. J Cell Sci 115:3491–3496
O'ShaughnessyPJ, BakerPJ, JohnstonH (2006) The foetal Leydig cell – differentiation, function and regulation. Int J Androl 29:90–95; discussion:105–108
OstrerH (2008) 46,XY disorder of sex development and 46,XY complete gonadal dysgenesis. In: PagonRA, BirdTD, DolanCR, StephensK (eds) GeneReviews [Internet]. University of Washington, Seattle [updated Sep 15, 2009]
PageST, KupelianV, BremnerWJ, McKinlayJB (2006) The androgen receptor gene CAG repeat polymorphism does not predict increased risk of heart disease: longitudinal results from the Massachusetts Male Ageing Study. Clin Endocrinol (Oxf) 65:333–339
PapadimitriouDT, LinglartA, MorelY, ChaussainJL (2006) Puberty in subjects with complete androgen insensitivity syndrome. Horm Res 65:126–131
PatrizioP, LeonardDG, ChenKL, Hernandez-AyupS, TrounsonAO (2001) Larger trinucleotide repeat size in the androgen receptor gene of infertile men with extremely severe oligozoospermia. J Androl 22:444–448
PerritonCL, PowlesN, ChiangC, MaconochieMK, CohnMJ (2002) Sonic hedgehog signaling from the urethral epithelium controls external genital development. Dev Biol 247:26–46
PioroEP, KantA, MitsumotoH (1994) Disease expression in a Kennedy's disease kindred is unrelated to CAG tandem repeat size in the androgen receptor gene: characterization in a symptomatic female. Ann Neurol 36:318
PiprekRP (2009) Genetic mechanisms underlying male sex determination in mammals. J Appl Genet 50:347–360
PlantTM (2006) The role of KiSS-1 in the regulation of puberty in higher primates. Eur J Endocrinol 155 (Suppl 1):S11–S16
PlantTM, WitchelSF (2006) Puberty in non-human primates and humans. In: NeillJD, PlantTM, PfaffDW, ChallisJRG, de KretserDM, RichardsJS, WassarmanPM (eds) Knobil and Neill's Physiology of Reproduction. Academic Press, St Louis, pp 2177–2230
PlatzEA, GiovannucciE, DahlDM, KrithivasK, HennekensCH, BrownM, StampferMJ, KantoffPW (1998) The androgen receptor gene GGN microsatellite and prostate cancer risk. Cancer Epidemiol Biomarkers Prev 7:379–384.
PlatzEA, RimmEB, WillettWC, KantoffPW, GiovannucciE (2000) Racial variation in prostate cancer incidence and in hormonal system markers among male health professionals. J Natl Cancer Inst 92:2009–2017
PodlasekCA, BarnettDH, ClemensJQ, BakPM, BushmanW (1999) Prostate development requires Sonic hedgehog expressed by the urogenital sinus epithelium. Dev Biol 209:28–39
PopeHG, CohaneGH, KanayamaG, SiegelAJ, HudsonJI (2003) Testosterone gel supplementation for men with refrectory depression: a randomized placebo-controlled trial. Am J Psychiatry 160:105–111
PriceH, McNealJE, StameyTA (1990) Evolving patterns of tissue composition in benign prostatic hyperplasia as a function of specimen size. Hum Pathol 21:578–585
QuigleyCA, De BellisA, MarschkeKB, el-AwadyMK, WilsonEM, FrenchFS (1995) Androgen receptor defects: historical, clinical, and molecular perspectives. Endocr Rev 16:271–321
Rajpert-De MeytsE, LeffersH, PetersenJH, AndersenAG, CarlsenE, JorgensenN, SkakkebaekNE (2002) CAG repeat length in androgen-receptor gene and reproductive variables in fertile and infertile men. Lancet 359:44–46
RemesT, VaisanenSB, MahonenA, HuuskonenJ, KrogerH, JurvelinJS, PenttilaIM, RauramaaR (2003) Aerobic exercise and bone mineral density in middle-aged Finnish men: a controlled randomized trial with reference to androgen receptor aromatase and estrogen receptor alpha gene polymorphisms. Bone 32:412–420
ReyRA, BelvilleC, Nihoul-FeketeC, Michel-CalemardL, ForestMG, LahlouN, JaubertF, MowszowiczI, DavidM, SakaN, BouvattierC, BertrandAM, LecointreC, SoskinS, CabrolS, CrosnierH, LegerJ, Lortat-JacobS, NicolinoM, RablW, ToledoSP, BasF, GompelA, CzernichowP, ChatelainP, RappaportR, MorelY, JossoN(1999) Evaluation of gonadal function in 107 intersex patients by means of serum antimullerian hormone measurement. J Clin Endocrinol Metab 84:627–631
RodienP, MebarkiF, MowszowiczI, ChaussainJL, YoungJ, MorelY, SchaisonG (1996) Different phenotypes in a family with androgen insensitivity caused by the same M780I point mutation in the androgen receptor gene. J Clin Endocrinol Metab 81:2994–2998
RossRK, PikeMC, CoetzeeGA, ReichardtJK, YuMC, FeigelsonH, StanczykFZ, KolonelLN, HendersonBE (1998) Androgen metabolism and Prostate Cancer: establishing a model of genetic susceptibility. Cancer Res 58:4497–4504
SackJS, KishKF, WangC, AttarRM, KieferSE, AnY, WuGY, SchefflerJE, SalvatiME, KrystekSR Jr, WeinmannR, EinspahrHM (2001) Crystallographic structures of the ligand-binding domains of the androgen receptor and its T877A mutant complexed with the natural agonist dihydrotestosterone. Proc Natl Acad Sci USA 98:4904–4909
SalmenT, HeikkinenAM, MahonenA, KrogerH, KomulainenM, PallonenH, SaarikoskiS, HonkanenR, MaenpaaPH (2003) Relation of androgen receptor gene polymorphism to bone mineral density and fracture risk in early postmenopausal women during a 5-year randomized hormone replacement therapy trial. J Bone Miner Res 18:319–324
Sapir-KorenR, LivshitsG, LandsmanT, KobylianskyE (2001) Bone mineral density is associated with estrogen receptor gene polymorphism in men. Anthropol Anzeiger 59:343–353
SasagawaI, SuzukiY, AshidaJ, NakadaT, MuroyaK, OgataT (2001) CAG repeat length analysis and mutation screening of the androgen receptor gene in Japanese men with idiopathic azoospermia. J Androl 22:804–808
SawayaME, ShalitaAR (1998) Androgen receptor polymorphisms (CAG repeat lengths) in androgenetic alopecia hirsutism and acne. J Cutan Med Surg 3:9–15
SchauwaersK, De GendtK, SaundersPT, AtanassovaN, HaelensA, CallewaertL, MoehrenU, SwinnenJV, VerhoevenG, VerrijdtG, ClaessensF (2007) Loss of androgen receptor binding to selective androgen response elements causes a reproductive phenotype in a knockin mouse model. Proc Natl Acad Sci USA 104:4961–4966
SchneiderG, NienhausK, GromollJ, HeuftG, NieschlagE, ZitzmannM (2011a) Depressive symptoms in men aged 50 years and older and their relationship to genetic androgen receptor polymorphism and sex hormone levels in three different samples. Am J Geriatr Psychiatry 19:274–283
SchneiderG, NienhausK, GromollJ, HeuftG, NieschlagE, ZitzmannM (2011b) Sex hormone levels, genetic androgen receptor polymorphism, and anxiety in ≥50-year-old males. J Sex Med 8:3452–3464
SchweigerU, DeuschleM, WeberB, KornerA, LammersCH, SchmiderJ (1999) Testosterone gonadotropin and cortisol secretion in male patients with major depression. Psychosom Med 61:292–296
SeidmanSN, AraujoAB, RooseSP, McKinlayJB (2001) Testosterone level androgen receptor polymorphism and depressive symptoms in middle-aged men. Biol Psych 50:371–376
SeifertAW, ZhengZ, OrmerodBK, CohnMJ (2010) Sonic hedgehog controls growth of external genitalia by regulating cell cycle kinetics. Nat Commun 1:23
SekidoR, Lovell-BadgeR (2008) Sex determination involves synergistic action of SRY and SF1 on a specific Sox9 enhancer. Nature 453:930–934
SekidoR, Lovell-BadgeR (2009) Sex determination and SRY: down to a wink and a nudge?Trends Genet 25:19–29
ShabsighR, ArverS, ChannerKS, EardleyI, FabbriA, GoorenL, HeufelderA, JonesH, MerynS, ZitzmannM (2008) The triad of erectile dysfunction, hypogonadism and the metabolic syndrome. Int J Clin Pract 62:791–798
ShafferPL, JivanA, DollinsDE, ClaessensF, GewirthDT (2004) Structural basis of androgen receptor binding to selective androgen response elements. Proc Natl Acad Sci USA 101:4758–4763
ShenJH, IngrahamHA (2002) Regulation of the orphan nuclear receptor steroidogenic factor 1 by Sox proteins. Mol Endocrinol 16:529–540
SimentalJA, SarM, LaneMV, FrenchFS, WilsonEM (1991) Transcriptional activation and nuclear targeting signals of the human androgen receptor. J Biol Chem 266:510–518
SinneckerGH, HiortO, NitscheEM, HolterhusPM, KruseK (1997) Functional assessment and clinical classification of androgen sensitivity in patients with mutations of the androgen receptor gene. German Collaborative Intersex Study Group. Eur J Pediatr 156:7–14
SongLN, HerrellR, ByersS, ShahS, WilsonEM, GelmannEP (2003) Beta-catenin binds to the activation function 2 region of the androgen receptor and modulates the effects of the N-terminal domain and TIF2 on ligand-dependent transcription. Mol Cell Biol 23:1674–1687
SowersM, WillingM, BurnsT, DeschenesS, HollisB, CrutchfieldM, JannauschM (1999) Genetic markers, bone mineral density, and serum osteocalcin levels. J Bone Min Res 14:1411–1419
StanfordJL, JustJJ, GibbsM, WicklundKG, NealCL, BlumensteinBA, OstranderEA (1997) Polymorphic repeats in the androgen receptor gene: molecular markers of prostate cancer risk. Cancer Res 57:1194–1198
StanworthRD, KapoorD, ChannerKS, JonesTH (2008) Androgen receptor CAG repeat polymorphism is associated with serum testosterone levels, obesity and serum leptin in men with type 2 diabetes. Eur J Endocrinol 159:739–746
SteltenkampS, HiortO (2007) Pubertal development of 46,XY DSD patients with partial androgen insensitivity due to mutation of the androgen receptor assigned to male sex. Horm Res 68:205
TaguchiO, CunhaGR, LawrenceWD, RobboySJ (1984) Timing and irreversibility of Mullerian duct inhibition in the embryonic reproductive tract of the human male. Dev Biol 106:394–398
TakedaH, LasnitzkiI, MizunoT (1986) Analysis of prostatic bud induction by brief androgen treatment in the fetal rat urogenital sinus. J Endocrinol 110:467–470
ThomasMA, PreeceDM, BentelJM (2010) Androgen regulation of the prostatic tumour suppressor NKX3.1 is mediated by its 3′ untranslated region. Biochem J 425:575–583
TilleyWD, MarcelliM, WilsonJD, McPhaulMJ (1989) Characterization and expression of a cDNA encoding the human androgen receptor. Proc Natl Acad Sci USA 86:327–331
TrapmanJ, KlaassenP, KuiperGG, van der KorputJA, FaberPW, van RooijHC, Geurts van KesselA, VoorhorstMM, MulderE, BrinkmannAO (1988) Cloning, structure and expression of a cDNA encoding the human androgen receptor. Biochem Biophys Res Commun 153:241–248
TutTG, GhadessyFJ, TrifiroMA, PinskyL, YongEL (1997) Long polyglutamine tracts in the androgen receptor are associated with reduced trans-activation impaired sperm production and male infertility. J Clin Endocr Metab 82:3777–3782
UndenF, LjunggrenJG, Beck-FriisJ, KjellmanF, WetterbergL (1988) Hypothalamic-pituitary-gonadal axis in major depressive disorders. Acta Psychiatri Scand 78:138–146
van GoldeR, Van HouwelingenK, KiemeneyL, KremerJ, TuerlingsJ, SchalkenJ, MeulemanE (2002) Is increased CAG repeat length in the androgen receptor gene a risk factor for male subfertility?J Urol 167:621–623
van HoutenME, GoorenLJ (2000) Differences in reproductive endocrinology between Asian men and Caucasian men—a literature review. Asian J Androl 2:13–20
Van PottelberghI, LumbrosoS, GoemaereS, SultanC, KaufmanJM (2001) Lack of influence of the androgen receptor gene CAG-repeat polymorphism on sex steroid status and bone metabolism in elderly men. Clin Endocrinol 55:659–666
von EckardsteinS, SyskaA, GromollJ, KamischkeA, SimoniM, NieschlagE (2001) Inverse correlation between sperm concentration and number of androgen receptor CAG repeats in normal men. J Clin Endocr Metab 86:2585–2590
von EckardsteinS, SchmidtA, KamischkeA, SimoniM, GromollJ, NieschlagE (2002) CAG repeat length in the androgen receptor gene and gonadotrophin suppression influence the effectiveness of hormonal male contraception. Clin Endocrinol 57:647–655
WallerandH, Remy-MartinA, ChabannesE, BermontL, AdessiGL, BittardH (2001) Relationship between expansion of the CAG repeat in exon 1 of the androgen receptor gene and idiopathic male infertility. Fertil Steril 76:769–774
WangC, NieschlagE, SwerdloffR, BehreHM, HellstromWJ, GoorenLJ, KaufmanJM, LegrosJJ, LunenfeldB, MoralesA, MorleyJE, SchulmanC, ThompsonIM, WeidnerW, WuFC (2008) Investigation, treatment and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA and ASA recommendations. Eur J Endocrinol 159:507–514
WangG, ChenG, WangX, ZhongJ, LuJ (2001) The polymorphism of (CAG)n repeats within androgen receptor gene among Chinese male population [article in Chinese]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi [Chinese Journal of Medical Genetics] 18:456–458
WangQ, UdayakumarTS, VasaitisTS, BrodieAM, FondellJD (2004) Mechanistic relationship between androgen receptor polyglutamine tract truncation and androgen-dependent transcriptional hyperactivity in prostate cancer cells. J Biol Chem 279:17319–17328
WarotX, Fromental-RamainC, FraulobV, ChambonP, DolleP (1997) Gene dosage-dependent effects of the Hoxa-13 and Hoxd-13 mutations on morphogenesis of the terminal parts of the digestive and urogenital tracts. Development 124:4781–4791
WelshM, MacLeodDJ, WalkerM, SmithLB, SharpeRM (2009) Critical androgen-sensitive periods of rat penis and clitoris development. Int J Androl 33:e144–e152
WernerR, HolterhusPM, BinderG, SchwarzHP, MorlotM, StruveD, MarschkeC, HiortO (2006a) The A645D mutation in the hinge region of the human androgen receptor (AR) gene modulates AR activity, depending on the context of the polymorphic glutamine and glycine repeats. J Clin Endocrinol Metab 91:3515–3520
WernerR, SchuttJ, HannemaS, RopkeA, WieackerP, HiortO, HolterhusPM (2006b) Androgen receptor gene mutations in androgen insensitivity syndrome cause distinct patterns of reduced activation of androgen-responsive promoter constructs. J Steroid Biochem Mol Biol 101:1–10
WernerR, GrotschH, HiortO (2010) 46,XY disorders of sex development – the undermasculinised male with disorders of androgen action. Best Pract Res Clin Endocrinol Metab 24:263–277
WilhelmD, MartinsonF, BradfordS, WilsonMJ, CombesAN, BeverdamA, BowlesJ, MizusakiH, KoopmanP (2005) Sertoli cell differentiation is induced both cell-autonomously and through prostaglandin signaling during mammalian sex determination. Dev Biol 287:111–124
WilhelmD, HiramatsuR, MizusakiH, WidjajaL, CombesAN, KanaiY, KoopmanP (2007) SOX9 regulates prostaglandin D synthase gene transcription in vivo to ensure testis development. J Biol Chem 282:10553–10560
YamadaG, SatohY, BaskinLS, CunhaGR (2003) Cellular and molecular mechanisms of development of the external genitalia. Differentiation 71:445–460
YamadaG, SuzukiK, HaraguchiR, MiyagawaS, SatohY, KamimuraM, NakagataN, KataokaH, KuroiwaA, ChenY (2006) Molecular genetic cascades for external genitalia formation: an emerging organogenesis program. Dev Dyn 235:1738–1752
YanovichR, MilgromR, FriedmanE, MoranDS (2011) Androgen receptor CAG repeat size is associated with stress fracture risk: a pilot study. Clin Orthop Relat Res 469:2925–2931
YaoHH, WhoriskeyW, CapelB (2002) Desert Hedgehog/Patched 1 signaling specifies fetal Leydig cell fate in testis organogenesis. Genes Dev 16:1433–1440
YehS, TsaiMY, XuQ, MuXM, LardyH, HuangKE, LinH, YehSD, AltuwaijriS, ZhouX, XingL, BoyceBF, HungMC, ZhangS, GanL, ChangC (2002) Generation and characterization of androgen receptor knockout (ARKO) mice: an in vivo model for the study of androgen functions in selective tissues. Proc Natl Acad Sci USA 99:13498–13503
YongEL, LimLS, WangQ, MifsudA, LimJ, OngYC, SimKS (2000) Androgen receptor polymorphisms and mutations in male infertility. J Endocrinol Invest 23:573–577
YoshidaKI, YanoM, ChibaK, HondaM, KitaharaS (1999) CAG repeat length in the androgen receptor gene is enhanced in patients with idiopathic azoospermia. Urology 54:1078–1081
ZeegersMP, KiemeneyLA, NiederAM, OstrerH (2004) How strong is the association between CAG and GGN repeat length polymorphisms in the androgen receptor gene and prostate cancer risk?Cancer Epidemiol Biomarkers Prev 13:1765–1771
ZeltserL, DesplanC, HeintzN (1996) Hoxb-13: a new Hox gene in a distant region of the HOXB cluster maintains colinearity. Development 122:2475–2484
ZhouX (2010) Roles of androgen receptor in male and female reproduction: lessons from global and cell-specific androgen receptor knockout (ARKO) mice. J Androl 31:235–243
ZhouZX, SarM, SimentalJA, LaneMV, WilsonEM (1994) A ligand-dependent bipartite nuclear targeting signal in the human androgen receptor. Requirement for the DNA-binding domain and modulation by NH2-terminal and carboxyl-terminal sequences. J Biol Chem 269:13115–13123
ZitzmannM, NieschlagE (2001) Testosterone levels in healthy men and the relation to behavioural and physical characteristics: facts and constructs. Euro J Endocrinol 144:183–197
ZitzmannM, BruneM, KornmannB, GromollJ, JunkerR, NieschlagE (2001a) The CAG repeat polymorphism in the androgen receptor gene affects bone density and bone metabolism in healthy males. Clin Endocrinol 55:649–657
ZitzmannM, BruneM, KornmannB, GromollJ, von EckardsteinS, von EckardsteinA, NieschlagE (2001b) The CAG repeat polymorphism in the AR gene affects high density lipoprotein cholesterol and arterial vasoreactivity. J Clin Endocr Metab 86:4867–4873
ZitzmannM, BruneM, NieschlagE (2002a) Vascular reactivity in hypogonadal men is reduced by androgen substitution. J Clin Endocr Metab 87:5030–5037
ZitzmannM, BruneM, ViethV, NieschlagE (2002b) Monitoring bone density in hypogonadal men by quantitative phalangeal ultrasound. Bone 31:422–429
ZitzmannM, GromollJ, von EckardsteinA, NieschlagE (2003a) The CAG repeat polymorphism in the androgen receptor gene modulates body fat mass and serum levels of leptin and insulin in men. Diabetologia 46:31–39
ZitzmannM, DepenbuschM, GromollJ, NieschlagE (2003b) Prostate volume and growth in testosterone-substituted hypogonadal men are dependent on the CAG repeat polymorphism of the androgen receptor gene: a longitudinal pharmacogenetic study. J Clin Endocrinol Metab 88:2049–2054
ZmudaJM, CauleyJA, KullerLH, NewmanAB, RobbinsJ, HarrisT, FerrellRE (2000a) Androgen receptor CAG repeat polymorphism: a novel marker of osteoporotic risk in men. Osteoporosis Int 11 S151: 355
ZmudaJM, CauleyJA, KullerLH, ZhangX, PalermoL, NevittMC, FerrellRE (2000b) Androgen receptor CAG repeat length is associated with increased hip bone loss and vertebral fracture risk among older men. J Bone Min Res 15 S491: M141